Device Trial Radar · NCT07875374
40 Hz Gamma Auditory Stimulation for Delirium Prevention in Critically Ill ICU Patients
Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
142
Planned (sponsor's estimate)
Start
Oct 31, 2026
Primary completion
Nov 30, 2028
Study completion Jan 31, 2029
Sponsor
- Lead sponsor
- Peking Union Medical College HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 15, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated device
- No
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Delirium is a common acute disturbance of attention and cognition among critically ill patients and is associated with prolonged mechanical ventilation, longer hospital stays, and increased mortality. This multicenter, quadruple-masked, randomized controlled trial will evaluate whether 40 Hz gamma auditory stimulation can help prevent delirium in mechanically ventilated adult ICU patients. A total of 142 participants aged 50 years or older who are expected to require mechanical ventilation for at least 48 hours will be randomly assigned in a 1:1 ratio to receive either 40 Hz gamma auditory stimulation or a silent audio track, in addition to standard ICU care. The assigned intervention will be delivered through identical earphones twice daily at 08:00 and 20:00, for 60 minutes per session, until extubation or Day 7 after randomization, whichever occurs first. The primary outcome is the number of delirium- and coma-free days during the first 7 days after randomization. Secondary outcomes include the incidence and duration of delirium during this period, duration of mechanical ventilation, length of ICU and hospital stay through Day 28, and 28-day all-cause mortality.
Conditions
- Delirium
Interventions
40 Hz Gamma Auditory StimulationDevice
40 Hz isochronic tones are presented synchronously to both ears through standardized high-fidelity wired in-ear noise-canceling earphones. The sound level is maintained at 65-70 decibels (dB). The intervention is administered twice daily at 08:00 and 20:00 for 60 minutes per session, beginning after randomization and continuing until extubation or Day 7 after randomization, whichever occurs first. Standard ICU care is provided concurrently.
Silent Audio ControlDevice
A silent audio track is presented through standardized high-fidelity wired in-ear noise-canceling earphones. The device appearance, wearing procedure, session schedule, and duration are matched to the experimental intervention. Sessions are administered twice daily at 08:00 and 20:00 for 60 minutes per session, beginning after randomization and continuing until extubation or Day 7 after randomization, whichever occurs first. Standard ICU care is provided concurrently.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Delirium- and Coma-Free Days During the First 7 Days After RandomizationTime frame: From randomization through Day 7.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.